BrainsWay Ltd.
BrainsWay focuses on developing cutting-edge medical devices that help advance the level of treatment offered to patients. To do so, BrainsWay’s advanced flagship technology of Deep Transcranial Magnetic Stimulation (Deep TMS) is expanding the treatment of mental health beyond what was thought possible. BrainsWay’s noninvasive Deep TMS treatment has been proven to offer significant results by directly stimulating deeper and broader areas of the brain, effectively treating conditions such as depression, obsessive-compulsive disorder, and smoking addiction. With numerous studies and a growing number of patients and healthcare providers attesting to its success, BrainsWay’s cutting-edge technology is boldly advancing the treatment of mental health disorders.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About us
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain four FDA-cleared indications backed by pivotal studies demonstrating clinically proven efficacy.
Current indications include major depressive disorder, obsessive-compulsive disorder, smoking addiction, and anxious depression. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with offices in Burlington, MA, Cresskill, NJ and Jerusalem, Israel, BrainsWay is committed to increasing global awareness and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit the news page.